Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

  • Yalu Liu1,
  • Xiaogan Wang1,
  • Ning Ding1,
  • Lan Mi2,
  • Lingyan Ping1,
  • Xuan Jin1, 3,
  • Jiao Li1,
  • Yan Xie1,
  • Zhitao Ying1,
  • Weiping Liu1,
  • Chen Zhang1,
  • Lijuan Deng1,
  • Yuqin Song1Email author and
  • Jun Zhu1Email author
BMC Cancer201717:743

https://doi.org/10.1186/s12885-017-3760-0

Received: 30 June 2017

Accepted: 6 November 2017

Published: 10 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
30 Jun 2017 Submitted Original manuscript
17 Jul 2017 Reviewed Reviewer Report - Aditya Dutta
24 Jul 2017 Reviewed Reviewer Report - Simone Ferrero
22 Aug 2017 Author responded Author comments - Yalu Liu
Resubmission - Version 2
22 Aug 2017 Submitted Manuscript version 2
29 Aug 2017 Reviewed Reviewer Report - Simone Ferrero
26 Sep 2017 Author responded Author comments - Yalu Liu
Resubmission - Version 3
26 Sep 2017 Submitted Manuscript version 3
Publishing
6 Nov 2017 Editorially accepted
10 Nov 2017 Article published 10.1186/s12885-017-3760-0

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute
(2)
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute
(3)
Department of Internal Medicine Oncology, Peking University First Hospital

Advertisement